Pentling, Germany

Walter Schwarz

This inventor holds 1 USPTO granted patent. Top assignee: Asta-Werke Aktiengesellschaft. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walter Schwarz. Retrieved from https://idiyas.com/inventor/walter-schwarz-20rtgveu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Walter Schwarz: Innovator in Antitumor Compounds

Introduction

Walter Schwarz is a notable inventor based in Pentling, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor compounds. His work focuses on innovative solutions for treating various types of cancer.

Latest Patents

Walter Schwarz holds a patent for derivatives of antitumor compounds. This patent includes a specific formula that addresses the treatment of estrogen-receptor-positive tumors and prostate carcinoma. The substituents in his formula can vary, representing a range of chemical groups that enhance the efficacy of the compounds.

Career Highlights

Throughout his career, Walter Schwarz has been associated with Asta-Werke Aktiengesellschaft, where he has contributed to groundbreaking research in oncology. His dedication to developing effective treatments has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Walter has collaborated with esteemed colleagues, including Helmut Schonenberger and Rolf W. Hartmann. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of cancer treatment methodologies.

Conclusion

Walter Schwarz's contributions to the field of antitumor compounds exemplify his commitment to improving cancer therapies. His innovative work continues to impact the pharmaceutical landscape positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…